CCR5 (ccr5_human)
FAMILY
Class A (Rhodopsin) Protein receptors Chemokine receptors CCR5
GENE
CCR5
ORGANISM
Human (Homo sapiens)
ALT. NAMES
C-C chemokine receptor type 5, C-C CKR-5, CC-CKR-5, CCR-5, CCR5, CHEMR13, HIV-1 fusion coreceptor, CD195
SOURCE
SWISSPROT
SEQUENCE
| N-term | |||||||||
|
M
|
D
|
Y
|
Q
|
V
|
S
|
S
|
P
|
I
|
Y
|
| 10 | |||||||||
|
D
|
I
|
N
|
Y
|
Y
|
T
|
S
|
E
|
P
|
C
|
| 20 | |||||||||
| TM1 | |||||||||
|
Q
|
K
|
I
|
N
|
V
|
K
|
Q
|
I
|
A
|
A
|
| 30 | |||||||||
|
R
|
L
|
L
|
P
|
P
|
L
|
Y
|
S
|
L
|
V
|
| 40 | |||||||||
|
F
|
I
|
F
|
G
|
F
|
V
|
G
|
N
|
M
|
L
|
| 50 | |||||||||
|
V
|
I
|
L
|
I
|
L
|
I
|
N
|
C
|
K
|
R
|
| 60 | |||||||||
| ICL1 | TM2 | ||||||||
|
L
|
K
|
S
|
M
|
T
|
D
|
I
|
Y
|
L
|
L
|
| 70 | |||||||||
|
N
|
L
|
A
|
I
|
S
|
D
|
L
|
F
|
F
|
L
|
| 80 | |||||||||
|
L
|
T
|
V
|
P
|
F
|
W
|
A
|
H
|
Y
|
A
|
| 90 | |||||||||
| ECL1 | TM3 | ||||||||
|
A
|
A
|
Q
|
W
|
D
|
F
|
G
|
N
|
T
|
M
|
| 100 | |||||||||
|
C
|
Q
|
L
|
L
|
T
|
G
|
L
|
Y
|
F
|
I
|
| 110 | |||||||||
|
G
|
F
|
F
|
S
|
G
|
I
|
F
|
F
|
I
|
I
|
| 120 | |||||||||
|
L
|
L
|
T
|
I
|
D
|
R
|
Y
|
L
|
A
|
V
|
| 130 | |||||||||
| ICL2 | |||||||||
|
V
|
H
|
A
|
V
|
F
|
A
|
L
|
K
|
A
|
R
|
| 140 | |||||||||
| TM4 | |||||||||
|
T
|
V
|
T
|
F
|
G
|
V
|
V
|
T
|
S
|
V
|
| 150 | |||||||||
|
I
|
T
|
W
|
V
|
V
|
A
|
V
|
F
|
A
|
S
|
| 160 | |||||||||
|
L
|
P
|
G
|
I
|
I
|
F
|
T
|
R
|
S
|
Q
|
| 170 | |||||||||
| ECL2 | |||||||||
|
K
|
E
|
G
|
L
|
H
|
Y
|
T
|
C
|
S
|
S
|
| 180 | |||||||||
| TM5 | |||||||||
|
H
|
F
|
P
|
Y
|
S
|
Q
|
Y
|
Q
|
F
|
W
|
| 190 | |||||||||
|
K
|
N
|
F
|
Q
|
T
|
L
|
K
|
I
|
V
|
I
|
| 200 | |||||||||
|
L
|
G
|
L
|
V
|
L
|
P
|
L
|
L
|
V
|
M
|
| 210 | |||||||||
|
V
|
I
|
C
|
Y
|
S
|
G
|
I
|
L
|
K
|
T
|
| 220 | |||||||||
| ICL3 | TM6 | |||||||||
|
L
|
L
|
R
|
C
|
R
|
N
|
E
|
K
|
K
|
R
|
|
| 230 | ||||||||||
|
H
|
R
|
A
|
V
|
R
|
L
|
I
|
F
|
T
|
I
|
| 240 | |||||||||
|
M
|
I
|
V
|
Y
|
F
|
L
|
F
|
W
|
A
|
P
|
| 250 | |||||||||
|
Y
|
N
|
I
|
V
|
L
|
L
|
L
|
N
|
T
|
F
|
| 260 | |||||||||
| ECL3 | TM7 | ||||||||||
|
Q
|
E
|
F
|
F
|
G
|
L
|
N
|
N
|
C
|
S
|
||
| 270 | |||||||||||
|
S
|
S
|
N
|
R
|
L
|
D
|
Q
|
A
|
M
|
Q
|
| 280 | |||||||||
|
V
|
T
|
E
|
T
|
L
|
G
|
M
|
T
|
H
|
C
|
| 290 | |||||||||
|
C
|
I
|
N
|
P
|
I
|
I
|
Y
|
A
|
F
|
V
|
| 300 | |||||||||
| H8 | |||||||||
|
G
|
E
|
K
|
F
|
R
|
N
|
Y
|
L
|
L
|
V
|
| 310 | |||||||||
| C-term | |||||||||
|
F
|
F
|
Q
|
K
|
H
|
I
|
A
|
K
|
R
|
F
|
| 320 | |||||||||
|
C
|
K
|
C
|
C
|
S
|
I
|
F
|
Q
|
Q
|
E
|
| 330 | |||||||||
|
A
|
P
|
E
|
R
|
A
|
S
|
S
|
V
|
Y
|
T
|
| 340 | |||||||||
|
R
|
S
|
T
|
G
|
E
|
Q
|
E
|
I
|
S
|
V
|
| 350 | |||||||||
|
G
|
L
|
DIAGRAMS
7TM
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
CCL3 (Mouse), CCL7 (Human), CCL13 (Human), CCL11 (Rat), CCL16 (Human), CCL11 (Mouse), CCL8 (Human), CCL2 (Rat), CCL5 (Mouse), CCL14 (Human), CCL4 (Mouse), CCL5 (Human), CCL4 (Human), CCL3 (Rat), CCL3 (Human), CCL7 (Rat), CCL11 (Human), CCL2 (Human), CCL4 (Rat), CCL8 (Mouse), CCL7 (Mouse), CCL2 (Mouse)